Abstract:
The invention relates to antibodies against particular forms of enzymatically-inactive precursors of the prostate specific antigen (PSA), the production and use thereof in immunoassays for the determination of the [-5,-6,-7]-proPSA and application of the measured values from said assays, for an improved diagnosis in the field of prostate carcinomas.